Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Aminoglycoside antibiotic.
  • Fetal Risk
    Fetal Risk
  • May cuase maternal nephrotoxicity and ototoxicity with chronic prolonged use.
  • Crosses human placenta.
  • In general, use of aminoglycoside should be avoided in pregnancy because of potential fetal nephrotoxicity (gentamicin, amikacin, netilmicin) and ototoxicity (streptomycin and kanamycin).
  • Limited human data for Netilmicin, but poor fetal growth has been reported at high doses.
  • Should be used only in life threatening infections or if other medications are ineffective.
  • Fetal ototoxicity has not been reported in animals.
  • Breast Feeding
    Breast Feeding
  • Excreted into milk in small amounts.
  • No adverse effects in nursing infants have been reported.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     7   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year